1st Global AYA Cancer Congress, Edinburgh, 5-7 Dec 2016
Save the date and register your interest!
News
FDA Approves Expanded Indication for Medical Device to Treat Glioblastoma Multiforme
Indicated for patients with newly-diagnosed glioblastoma multiforme
European Medicines Agency Recommends Granting Marketing Authorisation for Cinacalcet Mylan
It is intended for the reduction of hypercalcaemia in patients with parathyroid carcinoma
ECC 2015 Press Release: Genetic Screening of Brain Metastases Could Reveal New Targets for Treatment
Researchers report that the original cancer in a patient’s body may have important differences at a genetic level from cancer that has spread to the patient’s brain
ECC 2015 Press Release: Results of International Trial Show Promise in Rare, Difficult to Treat Cancer: results from the RADIANT-4 trial
An international team of researchers has shown that the use of the mTOR inhibitor everolimus can delay tumour growth among both gastrointestinal and lung NETs
ESMO @ ECC 2015: Regional Hyperthermia Added to Neoadjuvant Chemotherapy Doubles Length of Overall Survival in Patients With Localised High-Risk Soft Tissue Sarcoma
Long-term follow-up of EORTC study strongly supports adding regional hyperthermia to neoadjuvant chemotherapy
ECC 2015: Rare Cancer Activities & Highlights
The SIOPE Session, Tackling Rare Cancers Requiring Specialist Care: ERNs, & Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs
New drugs could stop the growth of drug-resistant childhood tumors
Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments
ESMO E-Learning: Multidisciplinary Treatment for Glioblastoma
Providing an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastomarovide an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastoma